NASDAQ:ANGO - Nasdaq - US03475V1017 - Common Stock - Currency: USD
Overall ANGO gets a fundamental rating of 2 out of 10. We evaluated ANGO against 189 industry peers in the Health Care Equipment & Supplies industry. ANGO may be in some trouble as it scores bad on both profitability and health. ANGO is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -14.5% | ||
ROE | -22.27% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 54.36% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.03 | ||
Debt/FCF | N/A | ||
Altman-Z | 1.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.21 | ||
Quick Ratio | 1.4 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | 6831.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:ANGO (5/2/2025, 1:18:40 PM)
9.27
+0.08 (+0.87%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 1.33 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 2.03 | ||
P/tB | 3.28 | ||
EV/EBITDA | 6831.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -14.5% | ||
ROE | -22.27% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 54.36% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.03 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | 120.41 | ||
Cap/Depr | 15.88% | ||
Cap/Sales | 1.5% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.21 | ||
Quick Ratio | 1.4 | ||
Altman-Z | 1.25 |